Hepatology

Singing Therapy: An Effective Treatment for Supragastric Belching

by

Singing Therapy vs. Diaphragmatic Breathing for Supragastric Belching A recent randomized controlled trial published in Clinical Gastroenterology and Hepatology identifies singing therapy as a more effective treatment than standard diaphragmatic breathing for supragastric belching. According to the study, 72.2% of patients undergoing singing therapy reported at least a 50% reduction in symptoms after one week, … Read more

New Genetic Marker Linked to Severe IBD

by

Researchers from the Wellcome Sanger Institute and the Francis Crick Institute have identified a genetic marker, HLA-DRB1*01:03, that correlates with more severe ulcerative colitis and Crohn’s disease. Published in The Lancet Gastroenterology and Hepatology, the study suggests that genetic testing could help clinicians identify high-risk patients for earlier intervention with advanced therapies. How does the … Read more

Ireland Urged to Recognize ‘Hidden Condition’ Symptoms

by

The “Celtic Gene”: Why Early Detection is Transforming Ireland’s Health Landscape Haemochromatosis, often dubbed the “Celtic Gene,” is a silent health crisis hiding in plain sight. As Ireland’s most common genetic condition, it affects a staggering number of people, yet it remains frequently overlooked by both patients and healthcare providers. With approximately 1 in 83 … Read more

Boosting Chronic Hepatitis B Treatment: The Power of Combination Therapy

by

New Research Challenges Traditional Management of Immune-Tolerant Chronic Hepatitis B For patients diagnosed with chronic hepatitis B in the immune-tolerant (IT) phase, clinical management has historically been characterized by monitoring rather than active intervention. However, new findings published in the Journal of Clinical and Translational Hepatology suggest that a more proactive approach involving pegylated interferon … Read more

Colbopasvir plus sofosbuvir achieves high cure rates in chronic hepatitis C

by

The New Frontier of Hepatitis C Treatment: Breaking the Barrier of “Difficult-to-Treat” Strains For years, the medical community has chased the “holy grail” of Hepatitis C (HCV) treatment: a regimen that is not only highly effective across all genotypes but also safe for patients with complex comorbidities. Recent real-world data from a multicenter study in … Read more

Long-term study supports tenofovir alafenamide for chronic hepatitis B

by

The Shift Toward Long-Term Safety in Hepatitis B Care For years, managing chronic hepatitis B (CHB) has been a balancing act between suppressing the virus and managing the side effects of medication. Recent long-term data is now highlighting a significant trend: the transition toward treatments that prioritize not just viral suppression, but the preservation of … Read more

Bacterial infections in patients with liver cirrhosis show rising prevalence and high mortality

by

Liver Cirrhosis and Rising Bacterial Infections: A Global Health Concern Bacterial infections (BIs) are a significant threat to individuals living with liver cirrhosis, a condition affecting millions worldwide. A recent meta-analysis, published in the Journal of Clinical and Translational Hepatology, paints a concerning picture: these infections are not only common but are also on the … Read more

Expert guidance on fecal microbiota transplantation in liver disease

by

Fecal Microbiota Transplantation: A Gut Feeling About the Future of Liver Disease Treatment For decades, the gut has been seen as a digestive workhorse. Now, groundbreaking research is revealing its profound influence on nearly every aspect of our health, particularly liver function. Fecal Microbiota Transplantation (FMT) – the process of transferring fecal bacteria from a … Read more

International commission calls for action against hepatocellular carcinoma

by

Tackling Liver Cancer: A Glimpse into the Future of Prevention and Treatment Liver cancer, particularly hepatocellular carcinoma (HCC), poses a significant global health challenge. News-Medical.net recently highlighted a comprehensive report published in The Lancet, offering a roadmap for addressing the rising burden of this disease. This commission, composed of experts across various fields, has laid … Read more

Prognostic value of ALBI score for all-cause mortality in metabolic associated fatty liver disease patients: a cohort study from NHANES 2003–2018 | BMC Gastroenterology

by

Decoding Liver Health: Future Trends in Assessment and Management As a health journalist with years of experience covering medical research, I’ve seen firsthand the evolution of how we understand and treat liver diseases. The article you’ve presented offers a fascinating look at how researchers are using the National Health and Nutrition Examination Survey (NHANES) data … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]